The overdose crisis in Ontario is often stereotyped as an “opioid injection” crisis. However, data show that significant numbers of overdoses are also being driven by stimulant drug use and inhalation drug use.
This June, CATIE and the Canadian Network on Hepatitis C (CanHepC) co-hosted a webinar on sustaining the hepatitis C response before and after the novel coronavirus disease (COVID-19) pandemic. We invited leaders in the hepatitis C field to explore the challenges that the pandemic has posed for hepatitis C elimination efforts, but also the opportunities that could be leveraged. Here are just five of the ways we can do this:
Recently I was asked to speak at an event organized by Alex McClelland and Nicole Greenspan called “Where Do We Go From Here? AIDS Organizing, Services, Bureaucracy & the State.” The event aimed to address a number of questions, including: What are the limits of current community-based practice based on engagement with the state? Are today’s AIDS service organizations (ASOs) adequately resourced and designed to undertake their intended role? Is the role sufficient to address the ongoing and emerging HIV issues that marginalized communities face? Due to state constraints, what are the consequences on advocacy possibilities for ASOs, or ASO...
